MITAS Medical
MITAS Medical builds a teleophthalmology platform — the MS1 smartphone-mounted slit-lamp device plus app, cloud, and web examination software — that connects non-specialist clinicians in rural, remote, and developing-country settings to remote ophthalmologists, sold B2B to hospitals, clinics, and government health programs.
- Company typePrivate
- Founded2017
- HeadquartersTokyo, Japan
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MITAS Medical does
MITAS Medical (株式会社 MITAS Medical) is a Tokyo-based, founder-led medical device and telemedicine company founded in April 2017 by Dr. Naofumi Kita, a practicing ophthalmologist. The company builds an end-to-end teleophthalmology platform branded "Mobile Eye Doctor" that connects medically underserved patients with remote ophthalmologists. Its core hardware, the MS1, is a smartphone-mountable mobile slit-lamp microscope co-developed with Takagi Seiko Corporation; its key design point is forehead-stabilized image capture that lets non-ophthalmologist clinicians take diagnostic-quality eye images and video without the roughly one year of training conventional slit-lamp operation requires. The MS1 is paired with three software components: the Thorrel Android app (patient records, medical interview input, and image capture), the Hodzzy cloud service (specialized ophthalmic data storage and synchronization), and the iYobow web system, where ophthalmologists review uploaded data, customize examination items per project, and generate PDF reports.
The company serves rural and remote-island clinics, non-ophthalmologist general practitioners, and developing-country health systems where ophthalmologists are scarce and concentrated in cities. It operates a B2B/B2G field-sales motion, selling devices and subscription software to hospitals, clinics, municipalities, and government health programs, with deals reached through government tenders, accelerator networks, and direct institutional outreach. Pricing is quote-based and not publicly disclosed; revenue mechanics combine MS1 hardware sales (distributed through the Takagi Seiko partnership and reportedly on market in 80 countries) with recurring software/subscription services. Go-to-market relies heavily on government and development-agency programs — JICA, JETRO, METI/Medical Excellence Japan — that fund pilots and verification studies as a precursor to broader deployment.
Operationally, MITAS has run pilots and projects in Mongolia (20 clinics; a 2021 tele-checkup project targeting 10,000+ residents), Cambodia, Indonesia (a JICA COVID-19 ICT study), Bangladesh (METI verification with SHIP International Hospital), and within Japan (Hiroshima remote islands and a Medical MaaS vehicle integration in Sakai Town with MONET Technologies). The company is privately held with a simple ownership structure; disclosed capital is approximately 100 million yen, and it has taken undisclosed-amount funding from Capital Medica Ventures (2019) and strategic corporate funding from Takagi Seiko (2020). Headcount is 11–50.
MITAS Medical firmographics
Firmographics- Name
- MITAS Medical
- Legal name
- 株式会社 MITAS Medical
- Website
- https://mitasmedical.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MITAS Medical builds a teleophthalmology platform — the MS1 smartphone-mounted slit-lamp device plus app, cloud, and web examination software — that connects non-specialist clinicians in rural, remote, and developing-country settings to remote ophthalmologists, sold B2B to hospitals, clinics, and government health programs.
- Ownership category
- akta.pro rank
MITAS Medical industry classification
Industry- Product category
- Teleophthalmology devices and platforms
- NAICS
- Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460), Offices of Physicians (6211)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)
- akta.pro primary industry
- Ophthalmology & Vision Telemedicine Platforms (HLALAGAL)
- akta.pro secondary industries
- Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment) (HLAHAJAM), Mobile Imaging Services (HLAFAKAC), Second Opinion & Expert Matching Platforms (HLALALAC)
Keywords
Where MITAS Medical is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
MITAS Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
Revenue model
- MS1 Device Sales: Sale of the MS1 smartphone-connected ophthalmic diagnostic hardware device. Jointly developed with Takagi Seiko Corporation. Currently available in 80 countries.
- Software/Subscription Services: Thorrel app, Hodzzy cloud storage, and iYobow examination system likely operate on a subscription or per-user basis for healthcare institutions. Revenue model details not fully publicly disclosed.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/B2B pricing for healthcare institutions |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
MITAS Medical product offering
Product offeringCore offering
MITAS Medical develops and sells the MS1, a smartphone-mounted mobile slit-lamp microscope that condenses traditional ophthalmic diagnostic imaging into a smartphone-attached device, enabling clinicians without ophthalmology training to capture diagnostic-quality eye images and videos. The MS1 is paired with the "Mobile Eye Doctor" teleophthalmology platform—Thorrel (patient-data Android app), Hodzzy (cloud storage), and iYobow (web examination system for remote ophthalmologists)—delivered to hospitals, clinics, government health programs, and international development organizations so that specialists can remotely examine patients in rural, remote-island, and underserved areas.
Product overview
MITAS Medical offers a unified telemedicine platform called Mobile Eye Doctor, comprising four integrated products: MS1 (a smartphone-connected ophthalmic diagnostic device), Thorrel (a smartphone application for patient data management and eye imaging), Hodzzy (a cloud service for data storage and sharing), and iYobow (a web-based examination system for ophthalmologists). These products work together to enable remote eye consultations, allowing clinicians without ophthalmology experience to capture eye images and connect with specialists for diagnosis and treatment recommendations.
Differentiator
Problem solved
Functional benefit
Brands
- Mobile Eye Doctor: Tele-medicine service that connects ophthalmologists and people who need ophthalmic care, using MS1 device and dedicated applications.
- MS1
- Thorrel
- Hodzzy
- iYobow
Products and services
- MS1 smartphone-connected ophthalmic device A mobile slit-lamp microscope condensed into a smartphone-mountable device (jointly developed with Takagi Seiko Corporation) that lets clinicians without ophthalmology training capture diagnostic-quality eye images and videos, with forehead stabilization support that reduces the conventional ~1 year of slit-lamp training to short practice. Available in 80 countries.
- Thorrel mobile application An Android application installed on smartphones connected to the MS1 device that manages patient information, captures medical interview input, and records eye images/videos linked to patient records for transmission to remote ophthalmologists.
- Hodzzy cloud service A cloud platform specialized in storing ophthalmic medical data, including eye images and examination data, enabling browser-based data access within organizations and automatic synchronization with the iYobow examination system.
- iYobow web examination system A web-based service enabling professional ophthalmologists to perform eye examinations based on MS1 image data and medical interview information, with project-customized examination items, automated notifications, and PDF report generation.
- Mobile Eye Doctor teleophthalmology service End-to-end telemedicine service connecting ophthalmologists with patients and general clinicians in areas with limited access to eye care, integrating the MS1 device, Thorrel application, Hodzzy cloud, and iYobow examination system into a three-step remote consultation workflow (data entry via smartphone app, specialist advice, on-screen confirmation).
Quantifiable outcome
- 100+ diagnoses per month in Mongolia pilot with early glaucoma detection cases preventing vision loss
- +4 more outcomes
Companies that use MITAS Medical
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
MITAS Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
MITAS Medical partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered key, supporting and core.
- JETRO (Japan External Trade Organization)keySelected for JETRO's Japan Tech Africa Challenge (April 2024) and organizing HEALTH DESIGN exhibition at Osaka-Kansai Expo (June 2025). JETRO provides international market development support, exhibition platforms, and trade organization credibility.
- JICA DXLabsupportingPublished CEO interview on JICA's digital transformation platform, providing marketing visibility and credibility for international development work.
- MONET Technologies Co., Ltd.keyDeveloped 'Multi-Task Vehicles' for Medical MaaS program in Sakai Town, Ibaraki Prefecture. MITAS Medical's teleophthalmology service was integrated into these vehicles for mobile eye care delivery to residents.
- Takagi Seiko Co., Ltd. (株式会社タカギセイコー)coreJoint development partner for MS1 smartphone-connected ophthalmic device. Takagi Seiko provided manufacturing expertise and production facilities while MITAS provided software and teleophthalmology platform. Takagi Seiko also provided funding/investment to MITAS Medical. MS1 devices are now sold in 80 countries through this partnership.
- SHIP International Hospital (Bangladesh)coreLocal medical institution partner in Bangladesh for Healthcare Industry International Promotion Project (METI FY2022). Cooperated during August 2022 visit for free health camps and provided access for MS1 system demonstration to local residents.
- Mongolian National University of Medical SciencescoreAcademic medical partner in Mongolia collaborating since 2019 for tele-examination system implementation. Assisted with placing MS1 devices in 20 clinics in western province and connecting them with city ophthalmologists.
- Mongolia Ministry of HealthcoreGovernment health ministry partner providing support and approvals for tele-examination pilot projects in Mongolia, enabling deployment of MS1 system across clinics.
- Hiroshima SandboxcoreSelected for D-EGGS PROJECT acceleration program. Hiroshima Sandbox provided funding (up to 13 million yen) and full prefecture as demonstration field for teleconsultation service implementation connecting remote island clinics with mainland ophthalmologists.
- JICA (Japan International Cooperation Agency)coreMultiple partnerships: (1) SDGs Business Support Project 2020 for Cambodia survey, (2) PoC partner for COVID-19 ICT countermeasures research with Indonesia demo, (3) DXLab interview publication. JICA provides credibility and funding for international healthcare projects.
- Medical Excellence JAPANcoreImplementing association for METI Healthcare Industry International Promotion Project. Provided support for MITAS's Bangladesh verification study project under this subsidized program.
- Sunrise Japan HospitalsupportingListed as partner company on MITAS Medical website, suggesting collaboration for teleophthalmology service deployment.
- Plug and Play JapansupportingSelected for Plug and Play Japan Acceleration Program Summer/Fall 2020 Batch (Hardtech & Health). Provided network access and business development support through global accelerator program.
- DIP CorporationsupportingSelected for AI.Accelerator program. Provided AI startup acceleration support and network access through DIP Corporation's program.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
MITAS Medical competitors and assessment
Company assessmentDirect peers
- Peek Vision: UK-based social enterprise building smartphone-based eye screening tools (Peek Acuity, Peek Retina) for use by non-specialists in low-resource settings. Closely comparable to MITAS in mission (preventable blindness) and smartphone-ophthalmology approach.
- Remidio Innovative Solutions: India-based company producing smartphone-based ophthalmic imaging devices (e.g., Fundus on Phone, 3nethra) used for screening and teleophthalmology. Comparable on hardware-software bundle and emerging-market teleophthalmology positioning.
- Phelcom Technologies: Brazil-based maker of Eyer — a portable, smartphone-connected retinal imaging device used by general clinicians and ophthalmologists for screening. Comparable on portable smartphone-ophthalmology imaging and emerging-market distribution.
- Forus Health: India-based developer of portable, low-cost ophthalmic screening devices (3nethra series) deployed across India, Africa, and Southeast Asia. Comparable on portable teleophthalmology hardware for underserved populations.
- D-EYE (iHealthScreen): Italy/US-based developer of smartphone retinal imaging adapters and screening platforms. Directly comparable product category (smartphone-attached ophthalmic hardware + tele-screening workflow) and customer base (non-ophthalmologists).
- oDocs Eye Care: New Zealand-based startup producing smartphone ophthalmoscope and retinal imaging adapters for teleophthalmology. Comparable on smartphone-attached ophthalmic hardware targeting non-specialist users.
Broad incumbents
- Nidek Co., Ltd. Established Japanese manufacturer of ophthalmic and optometric equipment including slit lamps and fundus cameras. Competes in the same clinical workflow (slit-lamp examination) that MITAS's MS1 device targets to disrupt.
- Haag-Streit Group: Swiss ophthalmic equipment manufacturer with a long-standing slit-lamp product line. Comparable as a traditional slit-lamp incumbent whose core product MITAS's MS1 is positioned to substitute in low-resource settings.
- Topcon Corporation: Japanese global incumbent in ophthalmic and optometric equipment (slit lamps, fundus cameras, OCT). Comparable as a Japan-headquartered ophthalmic device manufacturer, but operates at vastly larger scale and a much broader product portfolio than MITAS's MS1.
- Heidelberg Engineering: Germany-based ophthalmic imaging specialist (OCT, fundus imaging, perimetry). Comparable as an established ophthalmic diagnostics vendor, though positioned in the high-end clinical segment rather than MITAS's smartphone-portable niche.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
MITAS Medical social profiles
Digital presenceMITAS Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
MITAS Medical leadership team
Management profileNumber of profiles
Profiles2 records
MITAS Medical funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MITAS Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MITAS Medical
What does MITAS Medical do?
MITAS Medical develops and sells the MS1, a smartphone-mounted mobile slit-lamp microscope that condenses traditional ophthalmic diagnostic imaging into a smartphone-attached device, enabling clinicians without ophthalmology training to capture diagnostic-quality eye images and videos. The MS1 is paired with the "Mobile Eye Doctor" teleophthalmology platform—Thorrel (patient-data Android app), Hodzzy (cloud storage), and iYobow (web examination system for remote ophthalmologists)—delivered to hospitals, clinics, government health programs, and international development organizations so that specialists can remotely examine patients in rural, remote-island, and underserved areas.
Is MITAS Medical a public or private company?
MITAS Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was MITAS Medical founded?
MITAS Medical was founded in 2017. It employs 11 to 50 people.
Where is MITAS Medical based?
MITAS Medical is headquartered in Tokyo, Japan, in the Asia region.
How does MITAS Medical make money?
Two revenue lines are on record. MS1 Device Sales are the primary driver. The others are software/Subscription Services.
Who are MITAS Medical's main competitors?
Direct peers on record are Peek Vision, Remidio Innovative Solutions, Phelcom Technologies, Forus Health, D-EYE (iHealthScreen) and oDocs Eye Care. Broad incumbents are Nidek Co., Ltd., Haag-Streit Group, Topcon Corporation and Heidelberg Engineering.
Does MITAS Medical have an API?
No public API is recorded for MITAS Medical.
What industry is MITAS Medical in?
MITAS Medical's product category is Teleophthalmology devices and platforms. Its primary akta.pro industry code is HLALAGAL, Ophthalmology & Vision Telemedicine Platforms, with a secondary code of HLAHAJAM, Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment). Its NAICS code is 339115 and its SIC code is 3841.